Heather Brechbuhl
Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 9 | 2025 | 2116 | 1.770 |
Why?
| Receptors, Estrogen | 6 | 2025 | 423 | 1.480 |
Why?
| Cancer-Associated Fibroblasts | 2 | 2024 | 13 | 1.460 |
Why?
| Receptors, Progesterone | 3 | 2024 | 342 | 1.050 |
Why?
| Glutathione | 4 | 2011 | 333 | 0.930 |
Why?
| Naphthalenes | 4 | 2014 | 60 | 0.860 |
Why?
| Trachea | 3 | 2014 | 228 | 0.810 |
Why?
| Neoplastic Cells, Circulating | 1 | 2020 | 67 | 0.670 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2010 | 128 | 0.620 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2020 | 190 | 0.620 |
Why?
| Biomarkers, Tumor | 3 | 2021 | 1174 | 0.580 |
Why?
| Leukocytes, Mononuclear | 1 | 2020 | 543 | 0.570 |
Why?
| Neoplasm Metastasis | 1 | 2020 | 608 | 0.570 |
Why?
| Receptor, ErbB-2 | 2 | 2020 | 334 | 0.530 |
Why?
| Neoplasm Proteins | 2 | 2010 | 428 | 0.530 |
Why?
| CD146 Antigen | 3 | 2021 | 41 | 0.490 |
Why?
| Stem Cells | 3 | 2014 | 573 | 0.480 |
Why?
| src-Family Kinases | 1 | 2014 | 94 | 0.440 |
Why?
| Respiratory Mucosa | 3 | 2014 | 313 | 0.440 |
Why?
| Tumor Microenvironment | 4 | 2021 | 596 | 0.400 |
Why?
| Cell Lineage | 2 | 2011 | 333 | 0.400 |
Why?
| Cell Proliferation | 5 | 2025 | 2344 | 0.400 |
Why?
| Flavonoids | 1 | 2011 | 79 | 0.370 |
Why?
| Antibiotics, Antineoplastic | 1 | 2011 | 120 | 0.360 |
Why?
| Proto-Oncogene Proteins | 1 | 2014 | 638 | 0.360 |
Why?
| Carrier Proteins | 2 | 2014 | 731 | 0.340 |
Why?
| MCF-7 Cells | 3 | 2020 | 109 | 0.330 |
Why?
| Drug Resistance, Neoplasm | 3 | 2025 | 738 | 0.330 |
Why?
| Doxorubicin | 1 | 2011 | 319 | 0.330 |
Why?
| Prostaglandin D2 | 1 | 2009 | 20 | 0.320 |
Why?
| beta Catenin | 1 | 2011 | 221 | 0.320 |
Why?
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 1318 | 0.320 |
Why?
| Adenosine Triphosphate | 1 | 2010 | 475 | 0.280 |
Why?
| Tumor Cells, Cultured | 3 | 2020 | 929 | 0.260 |
Why?
| Estrogens | 3 | 2018 | 348 | 0.260 |
Why?
| Fatty Acid Synthase, Type I | 1 | 2025 | 11 | 0.240 |
Why?
| Head and Neck Neoplasms | 1 | 2009 | 527 | 0.220 |
Why?
| Tamoxifen | 3 | 2025 | 198 | 0.220 |
Why?
| Cell Communication | 1 | 2024 | 293 | 0.200 |
Why?
| Triglycerides | 1 | 2025 | 519 | 0.200 |
Why?
| Epithelial Cells | 3 | 2014 | 1063 | 0.190 |
Why?
| Aromatase Inhibitors | 1 | 2021 | 51 | 0.190 |
Why?
| Lipid Metabolism | 1 | 2025 | 492 | 0.190 |
Why?
| Cilia | 2 | 2014 | 176 | 0.190 |
Why?
| Cell Differentiation | 4 | 2014 | 1858 | 0.180 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2025 | 157 | 0.180 |
Why?
| Female | 10 | 2025 | 68274 | 0.180 |
Why?
| Cell Adhesion Molecules | 1 | 2021 | 177 | 0.180 |
Why?
| Gene Expression Regulation | 1 | 2010 | 2523 | 0.180 |
Why?
| Estrogen Receptor alpha | 1 | 2021 | 131 | 0.180 |
Why?
| Humans | 17 | 2025 | 129078 | 0.170 |
Why?
| Cell Line, Tumor | 5 | 2025 | 3114 | 0.160 |
Why?
| Lung Neoplasms | 2 | 2011 | 2357 | 0.160 |
Why?
| Antigens, Neoplasm | 1 | 2021 | 309 | 0.160 |
Why?
| Neoadjuvant Therapy | 1 | 2021 | 383 | 0.160 |
Why?
| Neoplasm Invasiveness | 1 | 2020 | 480 | 0.150 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 50 | 0.150 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 772 | 0.150 |
Why?
| Mice, Transgenic | 2 | 2014 | 2082 | 0.140 |
Why?
| RNA Polymerase III | 1 | 2017 | 26 | 0.140 |
Why?
| Polyadenylation | 1 | 2017 | 40 | 0.140 |
Why?
| Progestins | 1 | 2017 | 78 | 0.140 |
Why?
| ErbB Receptors | 1 | 2020 | 602 | 0.130 |
Why?
| Carcinogenesis | 1 | 2017 | 201 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 235 | 0.120 |
Why?
| Animals | 7 | 2024 | 34708 | 0.120 |
Why?
| Tyrphostins | 1 | 2014 | 16 | 0.120 |
Why?
| Microtubule Proteins | 1 | 2014 | 16 | 0.120 |
Why?
| Fibroblasts | 1 | 2020 | 946 | 0.120 |
Why?
| Benzothiazoles | 1 | 2014 | 32 | 0.120 |
Why?
| Regeneration | 2 | 2012 | 178 | 0.110 |
Why?
| Oxidative Stress | 2 | 2009 | 1221 | 0.100 |
Why?
| Quinazolines | 1 | 2014 | 245 | 0.100 |
Why?
| Mice | 6 | 2018 | 16583 | 0.100 |
Why?
| Prognosis | 1 | 2020 | 3793 | 0.100 |
Why?
| beta-Galactosidase | 1 | 2011 | 75 | 0.090 |
Why?
| Keratin-14 | 1 | 2010 | 15 | 0.090 |
Why?
| Enzyme Inhibitors | 1 | 2014 | 829 | 0.090 |
Why?
| Chalcones | 1 | 2010 | 9 | 0.090 |
Why?
| Transgenes | 1 | 2011 | 180 | 0.090 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 392 | 0.090 |
Why?
| Nuclear Proteins | 1 | 2014 | 644 | 0.080 |
Why?
| Chelating Agents | 1 | 2009 | 68 | 0.080 |
Why?
| tert-Butylhydroperoxide | 1 | 2009 | 10 | 0.080 |
Why?
| Fungal Proteins | 1 | 2010 | 129 | 0.080 |
Why?
| Cytoprotection | 1 | 2009 | 55 | 0.080 |
Why?
| Mitochondrial Diseases | 1 | 2009 | 89 | 0.080 |
Why?
| Gene Expression Profiling | 2 | 2017 | 1696 | 0.080 |
Why?
| Biological Transport | 1 | 2010 | 394 | 0.080 |
Why?
| Organometallic Compounds | 1 | 2009 | 104 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1189 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 372 | 0.080 |
Why?
| Benzimidazoles | 1 | 2009 | 158 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2009 | 487 | 0.070 |
Why?
| Amino Acids | 1 | 2010 | 470 | 0.070 |
Why?
| Oxidation-Reduction | 1 | 2010 | 1014 | 0.070 |
Why?
| Antioxidants | 1 | 2010 | 559 | 0.070 |
Why?
| Saccharomyces cerevisiae | 1 | 2010 | 517 | 0.060 |
Why?
| Obesity | 1 | 2018 | 2847 | 0.060 |
Why?
| Mice, Inbred C57BL | 2 | 2014 | 5282 | 0.060 |
Why?
| Models, Biological | 1 | 2010 | 1704 | 0.050 |
Why?
| Reactive Oxygen Species | 2 | 2017 | 578 | 0.050 |
Why?
| Biomarkers | 1 | 2011 | 3878 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2018 | 39 | 0.040 |
Why?
| 3' Untranslated Regions | 1 | 2017 | 137 | 0.030 |
Why?
| Mice, SCID | 1 | 2017 | 340 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2017 | 312 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 657 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 579 | 0.030 |
Why?
| Homeodomain Proteins | 1 | 2018 | 480 | 0.030 |
Why?
| Weight Gain | 1 | 2018 | 504 | 0.030 |
Why?
| Basal Bodies | 1 | 2014 | 15 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 799 | 0.030 |
Why?
| Mucociliary Clearance | 1 | 2014 | 43 | 0.030 |
Why?
| Signal Transduction | 2 | 2018 | 4867 | 0.030 |
Why?
| Centrioles | 1 | 2014 | 40 | 0.030 |
Why?
| Adipose Tissue | 1 | 2018 | 588 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2014 | 210 | 0.030 |
Why?
| rab GTP-Binding Proteins | 1 | 2014 | 73 | 0.030 |
Why?
| Protein Transport | 1 | 2014 | 424 | 0.030 |
Why?
| RNA Interference | 1 | 2014 | 448 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2014 | 577 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2014 | 835 | 0.020 |
Why?
| HEK293 Cells | 1 | 2014 | 674 | 0.020 |
Why?
| Mitochondria | 1 | 2017 | 840 | 0.020 |
Why?
| Cell Membrane | 1 | 2014 | 729 | 0.020 |
Why?
| Disease Progression | 1 | 2018 | 2607 | 0.020 |
Why?
| Diet | 1 | 2018 | 1205 | 0.020 |
Why?
| Apoproteins | 1 | 2009 | 13 | 0.020 |
Why?
| Heme Oxygenase-1 | 1 | 2009 | 62 | 0.020 |
Why?
| Electron Transport | 1 | 2009 | 111 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2009 | 88 | 0.020 |
Why?
| Copper | 1 | 2009 | 109 | 0.020 |
Why?
| Bronchi | 1 | 2010 | 255 | 0.020 |
Why?
| DNA, Mitochondrial | 1 | 2009 | 194 | 0.020 |
Why?
| Apoptosis | 1 | 2017 | 2485 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 310 | 0.020 |
Why?
| Male | 1 | 2014 | 63248 | 0.020 |
Why?
| Mice, Knockout | 1 | 2014 | 2774 | 0.020 |
Why?
| Iron | 1 | 2009 | 285 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 957 | 0.020 |
Why?
| DNA Damage | 1 | 2009 | 377 | 0.020 |
Why?
| Cell Survival | 1 | 2009 | 1085 | 0.020 |
Why?
| Flow Cytometry | 1 | 2009 | 1147 | 0.020 |
Why?
| Cells, Cultured | 1 | 2010 | 4063 | 0.010 |
Why?
| Phenotype | 1 | 2010 | 3062 | 0.010 |
Why?
| Adult | 1 | 2017 | 35423 | 0.010 |
Why?
|
|
Brechbuhl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|